{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:45:55Z","timestamp":1790703955947,"version":"4.1.0"},"reference-count":58,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0924270821000429_as1\"><jats:title>Objective:<\/jats:title><jats:p>Narcolepsy is a chronic sleep disorder long hypothesised to be an autoimmune disease. Complement-mediated immune mechanisms have not been investigated in detail in narcolepsy. Our aim was to establish the significance of classical pathway activation in narcolepsy.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000429_as2\"><jats:title>Methods:<\/jats:title><jats:p>Sera of 42 narcolepsy patients and 26 healthy controls were screened with ELISA to determine the levels of C1q, C3a, C4d and complement component 4 binding protein (C4BP). A home-made ELISA method was developed to detect antibodies to C4BP-alpha (anti-C4BPA). The correlation between complement levels and clinical findings was examined.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000429_as3\"><jats:title>Results:<\/jats:title><jats:p>C1q levels were significantly higher in narcolepsy patients while C4d and C4BP levels were significantly lower compared to healthy controls. C3a levels were comparable among patients and controls. Eleven narcolepsy patients showed serum anti-C4BPA levels. Total rapid eye movements (REM) time, sleep onset latency, REM sleep latency, sleep activity, percentage of wakefulness after sleep onset and Epworth sleepiness scale scores were correlated with levels of different complement factors.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000429_as4\"><jats:title>Conclusion:<\/jats:title><jats:p>Complement-mediated immune mechanisms might partake in narcolepsy pathogenesis. The precise role of autoantibodies on complement level alterations needs to be investigated. Levels of complement factors and degradation products may potentially be utilised as biomarkers to predict the clinical severity of narcolepsy.<\/jats:p><\/jats:sec>","DOI":"10.1017\/neu.2021.42","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:40:56Z","timestamp":1642401656000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Classical complement pathway factor alterations in narcolepsy"],"prefix":"10.1017","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-5291","authenticated-orcid":false,"given":"Hande","family":"Y\u00fcceer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Gezen Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00e7in","family":"Benbir \u015eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdin\u00e7","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Karadeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem \u0130smail","family":"K\u00fc\u00e7\u00fckali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"S0924270821000429_ref45","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.401"},{"key":"S0924270821000429_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.11.001"},{"key":"S0924270821000429_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2015.02.005"},{"key":"S0924270821000429_ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0540-1"},{"key":"S0924270821000429_ref5","volume-title":"International Classification of Sleep Disorders","year":"2014"},{"key":"S0924270821000429_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(02)00213-4"},{"key":"S0924270821000429_ref46","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2008.5"},{"key":"S0924270821000429_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2011.00955.x"},{"key":"S0924270821000429_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.02.003"},{"key":"S0924270821000429_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2016.08.001"},{"key":"S0924270821000429_ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00573"},{"key":"S0924270821000429_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2006.09.005"},{"key":"S0924270821000429_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05668.x"},{"key":"S0924270821000429_ref42","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8140"},{"key":"S0924270821000429_ref20","first-page":"zsw006","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy","volume":"40","author":"Jennum","year":"2017","journal-title":"Sleep"},{"key":"S0924270821000429_ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02237"},{"key":"S0924270821000429_ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00250"},{"key":"S0924270821000429_ref1","volume-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2017"},{"key":"S0924270821000429_ref4","volume-title":"The International Classification of Sleep Disorders : Diagnostic and Coding Manual","year":"2005"},{"key":"S0924270821000429_ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00418"},{"key":"S0924270821000429_ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08774-1"},{"key":"S0924270821000429_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2005.11.005"},{"key":"S0924270821000429_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa055"},{"key":"S0924270821000429_ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00874.x"},{"key":"S0924270821000429_ref57","first-page":"6685929","article-title":"Proteomic profiling reveals the molecular changes of insomnia patients","volume":"2021","author":"Wang","year":"2021","journal-title":"BioMed Research International"},{"key":"S0924270821000429_ref2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.6.3998"},{"key":"S0924270821000429_ref28","first-page":"E12323","article-title":"Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy","volume":"115","author":"Luo","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"S0924270821000429_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx093"},{"key":"S0924270821000429_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.06.006"},{"key":"S0924270821000429_ref7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2018"},{"key":"S0924270821000429_ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1711.2006.01470.x"},{"key":"S0924270821000429_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1439-8"},{"key":"S0924270821000429_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155103"},{"key":"S0924270821000429_ref9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.286427"},{"key":"S0924270821000429_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2021.07.024"},{"key":"S0924270821000429_ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-018-0033-7"},{"key":"S0924270821000429_ref40","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00310-2019"},{"key":"S0924270821000429_ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-016-0060-5"},{"key":"S0924270821000429_ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0400-0"},{"key":"S0924270821000429_ref53","article-title":"Anti-tribbles pseudokinase 2 (TRIB2)-immunization modulates hypocretin\/orexin neuronal functions","volume":"40","author":"Tanaka","year":"2017","journal-title":"Sleep"},{"key":"S0924270821000429_ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.100"},{"key":"S0924270821000429_ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1985.tb02206.x"},{"key":"S0924270821000429_ref39","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314547791"},{"key":"S0924270821000429_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2015.11.014"},{"key":"S0924270821000429_ref38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120325"},{"key":"S0924270821000429_ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013320"},{"key":"S0924270821000429_ref52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-061010-113810"},{"key":"S0924270821000429_ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0097-x"},{"key":"S0924270821000429_ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.2.143"},{"key":"S0924270821000429_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-83387-8_4"},{"key":"S0924270821000429_ref10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403068"},{"key":"S0924270821000429_ref30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.sleep.2018.08.024","article-title":"Correlation between HLA-DQB1*06: 02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis","volume":"52","author":"Manni","year":"2018","journal-title":"Sleep Medicine"},{"key":"S0924270821000429_ref51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7612"},{"key":"S0924270821000429_ref32","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-186460"},{"key":"S0924270821000429_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0885-4505(91)90040-R"},{"key":"S0924270821000429_ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81969-8"},{"key":"S0924270821000429_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2008.11.003"},{"key":"S0924270821000429_ref43","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02811-14"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270821000429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T02:54:04Z","timestamp":1660618444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270821000429\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0924270821000429"],"URL":"https:\/\/doi.org\/10.1017\/neu.2021.42","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"value":"0924-2708","type":"print"},{"value":"1601-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"\u00a9 The Author(s), 2022. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}